关注
Edgar López-López
Edgar López-López
Pharmacology department - CINVESTAV
在 cinvestav.mx 的电子邮件经过验证
标题
引用次数
引用次数
年份
Computational drug design methods—current and future perspectives
FD Prieto-Martínez, E López-López, KE Juárez-Mercado, ...
In silico drug design, 19-44, 2019
151*2019
DataWarrior: An evaluation of the open-source drug discovery tool
E López-López, JJ Naveja, JL Medina-Franco
Expert Opinion on Drug Discovery 14 (4), 335-341, 2019
922019
Informatics for chemistry, biology, and biomedical sciences
E López-López, J Bajorath, JL Medina-Franco
Journal of chemical information and modeling 61 (1), 26-35, 2020
762020
Chemical multiverse: an expanded view of chemical space
JL Medina‐Franco, AL Chávez‐Hernández, E López‐López, ...
Molecular Informatics 41 (11), 2200116, 2022
452022
Progress on open chemoinformatic tools for expanding and exploring the chemical space
JL Medina-Franco, N Sánchez-Cruz, E López-López, BI Díaz-Eufracio
Journal of Computer-Aided Molecular Design 36 (5), 341-354, 2022
412022
Yes SIR! On the structure–inactivity relationships in drug discovery
E López-López, E Fernández-de Gortari, JL Medina-Franco
Drug Discovery Today 27 (8), 2353-2362, 2022
372022
Reaching for the bright StARs in chemical space
JL Medina-Franco, JJ Naveja, E López-López
Drug Discovery Today 24 (11), 2162-2169, 2019
332019
Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease
MG Santibáñez-Morán, E López-López, FD Prieto-Martínez, ...
RSC advances 10 (42), 25089-25099, 2020
322020
Activity landscape and molecular modeling to explore the SAR of dual epigenetic inhibitors: A focus on G9a and DNMT1
E López-López, FD Prieto-Martínez, JL Medina-Franco
Molecules 23 (12), 3282, 2018
272018
Bridging informatics and medicinal inorganic chemistry: toward a database of metallodrugs and metallodrug candidates
JL Medina-Franco, E López-López, E Andrade, L Ruiz-Azuara, A Frei, ...
Drug Discovery Today 27 (5), 1420-1430, 2022
242022
Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach
E López-López, O Rabal, J Oyarzabal, JL Medina-Franco
Journal of Computer-Aided Molecular Design 34 (6), 659-669, 2020
232020
Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds
J Bajorath, AL Chávez-Hernández, M Duran-Frigola, ...
Journal of Cheminformatics 14 (1), 82, 2022
222022
Tubulin inhibitors: a chemoinformatic analysis using cell-based data
E López-López, CM Cerda-García-Rojas, JL Medina-Franco
Molecules 26 (9), 2483, 2021
192021
In silico tools to study molecular targets of neglected diseases: inhibition of TcSir2rp3, an epigenetic enzyme of Trypanosoma cruzi
E López-López, C Barrientos-Salcedo, FD Prieto-Martínez, ...
Advances in protein chemistry and structural biology 122, 203-229, 2020
182020
Conformal prediction of HDAC inhibitors
U Norinder, JJ Naveja, E Lopez-Lopez, D Mucs, JL Medina-Franco
SAR and QSAR in Environmental Research 30 (4), 265-277, 2019
172019
Chemical space, diversity and activity landscape analysis of estrogen receptor binders
JJ Naveja, U Norinder, D Mucs, E López-López, JL Medina-Franco
RSC advances 8 (67), 38229-38237, 2018
132018
Exploring activity landscapes with extended similarity: is Tanimoto enough?
TB Dunn, E López‐López, TD Kim, JL Medina‐Franco, ...
Molecular Informatics 42 (7), 2300056, 2023
102023
7-Aminoalkoxy-quinazolines from epigenetic focused libraries are potent and selective inhibitors of DNA methyltransferase 1
JL Medina-Franco, E López-López, LP Martínez-Fernández
Molecules 27 (9), 2892, 2022
82022
The essence and transcendence of scientific publishing
JL Medina-Franco, E López-López
Frontiers in Research Metrics and Analytics 7, 822453, 2022
82022
Sampling and mapping chemical space with extended similarity indices
K López-Pérez, E López-López, JL Medina-Franco, RA Miranda-Quintana
Molecules 28 (17), 6333, 2023
72023
系统目前无法执行此操作,请稍后再试。
文章 1–20